Trial intelligence / Profile preview

Typhoid vaccine human challenge trial of Typbar-TCV versus TYPHIM Vi versus MENVEO

2014-002978-36Phase 2Unknown

Sponsor
University of Oxford
Start
Dec 2014
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in typhoid fever comparing Typbar-TCV, TYPHIM Vi and MENVEO control (3 arms). Status: unknown.

02

Drugs

typhoid conjugate vaccinesalmonella typhi capsular polysaccharide vaccinemeningococcal A conjugate vaccine
03

Conditions

typhoid fever

Beyond the preview

Go deeper on 2014-002978-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002978-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call